Advancing Nuclear Medicine to New Heights Through Radiotherapy Alliance

--Successful Conclusion of 'International Healthcare & Nuclear Medicine Alliance' Symposium

On September 13, a significant event focusing on cooperation and development in the fields of radiotherapy and nuclear medicine—the "International Medical · Nuclear Medicine Alliance" Work Exchange Conference—was successfully held at the Heavy Ion Hospital Campus of Wuwei Cancer Hospital in Gansu Province. The conference attracted over 50 participants from more than 20 alliance representatives, including the People's Health Publishing House and Foundation under the National Health Commission, the Radiation Oncology Branch of the Chinese Medical Association, the Beihai Municipal Health Commission, Changchun Cancer Hospital, Jiamusi Cancer Hospital, Pengbo Boao Boron Neutron Hospital, Beihai People's Hospital, Beihai Second People's Hospital, Beihai Traditional Chinese Medicine Hospital, the Affiliated Hospital of Beihai Health School, China Biotech Services Group (HK.8037), CNNC Medical Industry Management Co., Ltd., CNNC Zhouxin Medical Technology Co., Ltd., and the ARNM International English Journal. The attendees gathered to jointly plan collaborations and explore development opportunities.

Meeting site

The conference commenced under the chairmanship of Professor Wang Junjie, Chairman of the Radiation Oncology Branch of the Chinese Medical Association. Dean Ye Yancheng of Wuwei Cancer Hospital in Gansu Province first introduced the hospital and its heavy ion therapy project in detail, showcasing the institution’s latest achievements and future prospects in the field of nuclear medicine. Following this, Ms. Gao Naijun from the Quality and Safety Department of CNNC Medical Industry Management Co., Ltd. provided an in-depth yet accessible overview of the China Nuclear Medicine Operations Consortium plan, offering valuable insights and inspiration to the attendees. Director Zhu Fuhai of Pengbo Boao Boron Neutron Hospital then gave a comprehensive presentation on BNCT technology (Asia-Pacific Research Institute), highlighting its broad application potential in the nuclear medicine sector. Additionally, Professor Li Zhaolin from ARNM International English Journal introduced the journal’s role in facilitating international academic exchange, providing participants with a window into global research trends.

In recent years, Wuwei Cancer Hospital in Gansu Province has leveraged the radiating influence of its Heavy Ion Therapy Center, focusing on nuclear medicine technologies such as α-isotope targeted drugs. The hospital is committed to achieving precise radionuclide diagnosis and treatment, as well as the research, development, and translation of radioactive drugs, while actively building a model hospital for synergistic treatment using multiple radionuclides. To this end, the hospital has established a standardized Department of Nuclear Medicine and radionuclide therapy wards. It has also set up an isotope laboratory dedicated to core technology research, integration of key equipment, and demonstration of new industries. Additionally, in strict compliance with radiation protection regulations and standards, the hospital has launched radionuclide therapy wards that meet standardized construction requirements.

The hospital has introduced advanced equipment such as high-end PET-CT and SPECT-CT, and has launched multiple radionuclide therapy programs, including iodine-131 (¹³¹I) treatment for hyperthyroidism, strontium-90/yttrium-90 (⁹⁰Sr-⁹⁰Y) patch therapy for keloids, and strontium-89 (⁸⁹Sr) radionuclide therapy for bone metastases. Additionally, the hospital is preparing to introduce cutting-edge radionuclide treatments, such as radium-223 (²²³Ra) therapy for bone metastases in castration-resistant prostate cancer, as well as yttrium-90 (⁹⁰Y) microsphere embolization for primary liver cancer and colorectal liver metastases. Moving forward, the hospital will continue to leverage its medical and technological strengths to develop a comprehensive nuclear medicine industrial park integrating healthcare, research, education, and industry.

The successful convening of the "International Medical · Nuclear Medicine Alliance" Work Exchange Conference carries profound significance. Experts in attendance explored, from a global perspective, the establishment of an open and inclusive shared platform aimed at integrating domestic resources to form a united and mutually supportive medical alliance. Guided by the principle of "not owning everything, but making the best use of all available resources," the alliance seeks to facilitate the sharing of high-end medical equipment, technologies, and talent. To date, the alliance has preliminarily established its organizational structure, assembled a strong team of experts, formed an operational team, set up a China Medical Consultation Center, and launched a dedicated communication platform. Moving forward, it will serve as a bridge to connect various stakeholders, promote differentiated development among member institutions, leverage regional strengths, and create a platform for in-depth exchange and collaboration. This exchange conference not only brought together professionals from various medical sectors but also injected new vitality into the international medical field.

Visit the site

Post-Meeting Group Photo